15-75726138-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000332145.3(CIMAP1C):c.310C>A(p.Gln104Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,613,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000332145.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODF3L1 | NM_175881.5 | c.310C>A | p.Gln104Lys | missense_variant | 3/4 | ENST00000332145.3 | NP_787077.1 | |
ODF3L1 | XM_006720414.4 | c.361C>A | p.Gln121Lys | missense_variant | 3/4 | XP_006720477.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIMAP1C | ENST00000332145.3 | c.310C>A | p.Gln104Lys | missense_variant | 3/4 | 1 | NM_175881.5 | ENSP00000329584 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000857 AC: 13AN: 151604Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250364Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135408
GnomAD4 exome AF: 0.000139 AC: 203AN: 1461530Hom.: 0 Cov.: 31 AF XY: 0.000144 AC XY: 105AN XY: 727028
GnomAD4 genome AF: 0.0000857 AC: 13AN: 151604Hom.: 0 Cov.: 33 AF XY: 0.0000541 AC XY: 4AN XY: 73948
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 21, 2022 | The c.310C>A (p.Q104K) alteration is located in exon 3 (coding exon 3) of the ODF3L1 gene. This alteration results from a C to A substitution at nucleotide position 310, causing the glutamine (Q) at amino acid position 104 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at